
    
      The objective of this study is to prospectively evaluate the performance of Integra Accell
      Evo3 Demineralized Bone Matrix as an adjunct for instrumented lumbar spine fusion in
      comparison to a retrospective cohort of Infuse subjects. Infuse subjects were not enrolled in
      the current study.
    
  